In: American Journal of Epidemiology, 2018, vol. 187, no. 8, p. 1714-1720
|
In: Contributions to Mineralogy and Petrology, 2015, vol. 170, no. 2, p. 1-27
|
In: Journal of AOAC International, 2017, vol. 100, no. 4, p. 1170-1176
|
In: SLEEP, 2018, vol. 41, no. 7, p. -
|
In: The European Physical Journal A, 2015, vol. 51, no. 11, p. 1-10
|
In: The American Journal of Clinical Nutrition, 2016, vol. 104, no. 1, p. 236-237
|
In: The Journal of Infectious Diseases, 2016, vol. 213, no. 5, p. 794-799
|
In: Mathematical Programming, 2015, vol. 151, no. 1, p. 35-62
|
In: SLEEP, 2018, vol. 41, no. 7, p. -
|
In: Blood, 2020, vol. 135, no. 15, p. 1244–1254
CD49d is a remarkable prognostic biomarker of chronic lymphocytic leukemia (CLL). The cutoff value for the extensively validated 30% of positive CLL cells is able to separate CLL patients into 2 subgroups with different prognoses, but it does not consider the pattern of CD49d expression. In the present study, we analyzed a cohort of 1630 CLL samples and identified the presence of ∼20% of CLL...
|